These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22470466)

  • 1. In silico investigation of potential SRC kinase ligands from traditional Chinese medicine.
    Tou WI; Chen CY
    PLoS One; 2012; 7(3):e33728. PubMed ID: 22470466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese medicine as dual guardians against hypertension and cancer?
    Tou WI; Chen CY
    J Biomol Struct Dyn; 2012; 30(3):299-317. PubMed ID: 22694277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?
    Chen KC; Chang SS; Tsai FJ; Chen CY
    J Biomol Struct Dyn; 2013; 31(11):1219-35. PubMed ID: 23146021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of N(9)-arenthenyl purines as novel DFG-in and DFG-out dual Src/Abl inhibitors using 3D-QSAR, docking and molecular dynamics simulations.
    Ma S; Zeng G; Fang D; Wang J; Wu W; Xie W; Tan S; Zheng K
    Mol Biosyst; 2015 Feb; 11(2):394-406. PubMed ID: 25406390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study.
    Tsou YA; Chen KC; Lin HC; Chang SS; Chen CY
    PLoS One; 2012; 7(11):e50087. PubMed ID: 23209648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory enhancement by traditional Chinese medicine?
    Hung IC; Chang SS; Chang PC; Lee CC; Chen CY
    J Biomol Struct Dyn; 2013 Dec; 31(12):1411-39. PubMed ID: 23249175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potent EGFR inhibitors from TCM Database@Taiwan.
    Yang SC; Chang SS; Chen HY; Chen CY
    PLoS Comput Biol; 2011 Oct; 7(10):e1002189. PubMed ID: 22022246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the inhibitors of histone-lysine N-methyltransferase SETD2 for acute lymphoblastic leukaemia from traditional Chinese medicine.
    Chang YL; Chen HY; Chen KB; Chen KC; Chang KL; Chang PC; Chang TT; Chen YC
    SAR QSAR Environ Res; 2016 Jul; 27(7):589-608. PubMed ID: 27218135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Reoptimization of Binding Affinity and Drug-Resistance Circumvention Ability in Kinase Inhibitors: A Case Study with RL-45 and Src Kinase.
    Koneru JK; Sinha S; Mondal J
    J Phys Chem B; 2019 Aug; 123(31):6664-6672. PubMed ID: 31310546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine.
    Chen KY; Chang SS; Chen CY
    PLoS One; 2012; 7(9):e43932. PubMed ID: 22970152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome.
    Chen KC; Lee WY; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():139492. PubMed ID: 25045657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing.
    Patil R; Das S; Stanley A; Yadav L; Sudhakar A; Varma AK
    PLoS One; 2010 Aug; 5(8):e12029. PubMed ID: 20808434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers.
    Chen KC; Chen KB; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():189495. PubMed ID: 25089263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.
    Chen KC; Lee WY; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():429486. PubMed ID: 25089269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.
    Zhang Y; Zhang TJ; Tu S; Zhang ZH; Meng FH
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs.
    Jiang L; Zhang X; Chen X; He Y; Qiao L; Zhang Y; Li G; Xiang Y
    Molecules; 2015 Jul; 20(7):12769-86. PubMed ID: 26184151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor.
    Chen KB; Chen HY; Chen KC; Chen CY
    Biomed Res Int; 2014; 2014():950191. PubMed ID: 25050380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
    Venugopal PP; Das BK; Soorya E; Chakraborty D
    Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine.
    Chen KC; Sun MF; Chen CY
    Evid Based Complement Alternat Med; 2014; 2014():917605. PubMed ID: 24876881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.